Literature DB >> 29893052

Impact of major neonatal morbidities on adolescents born at 23-25 weeks of gestation.

Antti Holsti1, Fredrik Serenius1,2, Aijaz Farooqi1.   

Abstract

AIM: More infants born extremely preterm (EPT) are surviving, but major neonatal morbidities are consistently high. This study examined the impact of bronchopulmonary dysplasia (BPD), brain injuries and severe retinopathy of prematurity (ROP) on adolescents who were born EPT.
METHODS: We focused on EPT infants born at 23-25 weeks at the Swedish university hospitals in Uppsala and Umeå from January 1992 to December 1998. The poor outcome data covered 140 of 142 who survived to 36 weeks, and the chronic conditions data reported by parents covered 132 of 134 still alive at 10-15 years.
RESULTS: Of the 140 survivors at 36 weeks, 29 (21%) had poor outcomes: eight of 140 (6%) died, and 21 of 132 (16%) adolescent survivors had severe neurodevelopmental disabilities (NDD). BPD, severe ROP and/or brain injuries correlated independently with poor outcome. Of those adolescents who were free from BPD, brain injury and severe ROP, 6% had a severe NDD. The corresponding rates with any one, any two or all three neonatal morbidities were 21, 33 and 67%, respectively. BPD and brain injuries were associated with high rates of chronic conditions at 10-15 years of age resulting in functional limitations.
CONCLUSION: In adolescent EPT survivors, BPD and brain injuries were associated with high rates of chronic conditions and special healthcare needs. ©2018 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Chronic conditions; Extremely preterm infants; Long-term outcome; Neonatal morbidities; Neurodevelopmental outcome

Mesh:

Year:  2018        PMID: 29893052     DOI: 10.1111/apa.14445

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  6 in total

1.  Correlation of lateral ventricular size and deep gray matter volume in MRI at term equivalent age with neurodevelopmental outcome at a corrected age of 24 months and with handedness in preterm infants.

Authors:  Tobias Storbeck; Nora Bruns; Christel Weiss; Ursula Felderhoff-Müser; Hanna Müller
Journal:  Eur J Pediatr       Date:  2019-11-14       Impact factor: 3.183

2.  Placental proteins with predicted roles in fetal development decrease in premature infants.

Authors:  Cynthia Schreiner; Theresa L Powell; Claire Palmer; Thomas Jansson
Journal:  Pediatr Res       Date:  2022-02-07       Impact factor: 3.953

3.  Detailed statistical analysis plan for the SafeBoosC III trial: a multinational randomised clinical trial assessing treatment guided by cerebral oxygenation monitoring versus treatment as usual in extremely preterm infants.

Authors:  Mathias Lühr Hansen; Adelina Pellicer; Christian Gluud; Eugene Dempsey; Jonathan Mintzer; Simon Hyttel-Sorensen; Anne Marie Heuchan; Cornelia Hagmann; Gabriel Dimitriou; Gerhard Pichler; Gunnar Naulaers; Guoqiang Cheng; Ana Vilan; Jakub Tkaczyk; Karen B Kreutzer; Monica Fumagalli; Olivier Claris; Siv Fredly; Tomasz Szczapa; Theis Lange; Janus Christian Jakobsen; Gorm Greisen
Journal:  Trials       Date:  2019-12-19       Impact factor: 2.279

Review 4.  The Role of α1-Microglobulin (A1M) in Erythropoiesis and Erythrocyte Homeostasis-Therapeutic Opportunities in Hemolytic Conditions.

Authors:  Amanda Kristiansson; Magnus Gram; Johan Flygare; Stefan R Hansson; Bo Åkerström; Jill R Storry
Journal:  Int J Mol Sci       Date:  2020-09-30       Impact factor: 5.923

5.  Outcomes Following Post-Hemorrhagic Ventricular Dilatation among Infants of Extremely Low Gestational Age.

Authors:  Seetha Shankaran; Monika Bajaj; Girija Natarajan; Shampa Saha; Athina Pappas; Alexis S Davis; Susan R Hintz; Ira Adams-Chapman; Abhik Das; Edward F Bell; Barbara J Stoll; Michele C Walsh; Abbot R Laptook; Waldemar A Carlo; Krisa P Van Meurs; Pablo J Sánchez; M Bethany Ball; Ellen C Hale; Ruth Seabrook; Rosemary D Higgins
Journal:  J Pediatr       Date:  2020-07-30       Impact factor: 4.406

6.  Insulin-Like Growth Factor 1 in the Preterm Rabbit Pup: Characterization of Cerebrovascular Maturation following Administration of Recombinant Human Insulin-Like Growth Factor 1/Insulin-Like Growth Factor 1-Binding Protein 3.

Authors:  Magnus Gram; Claes Ekström; Bo Holmqvist; Galen Carey; Xiaoyang Wang; Suvi Vallius; William Hellström; Niklas Ortenlöf; Alex Adusei Agyemang; Lois E H Smith; Ann Hellström; Alexandra Mangili; Norman Barton; David Ley
Journal:  Dev Neurosci       Date:  2021-07-02       Impact factor: 2.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.